Karmarkar Meghana, Speziale Mark, Jenkins Willough, Heath Danielle, Kang Jane, Suvak Julia, Grimm Peggy, Moyer Laurel
From the Neonatal ICU, Department of Pediatrics, Kaiser Santa Clara, Santa Clara, Calif.
Department of Pediatrics, University of California San Diego, La Jolla, Calif.
Pediatr Qual Saf. 2024 Oct 21;9(6):e752. doi: 10.1097/pq9.0000000000000752. eCollection 2024 Nov-Dec.
Delirium is not commonly diagnosed in neonatal intensive care units and can adversely impact patient outcomes in the ICU setting. Recognition of delirium in the NICU is a necessary first step to address the potential impact on neonatal outcomes.
We conducted a quality improvement initiative implementing screening for neonatal delirium. We aimed to increase screening in NICU patients from 0% to 85% by March 2022. Interdisciplinary meetings were held with key stakeholders to develop a clinical algorithm. We used standardized tools for delirium screening. Our process measures included weekly nursing compliance with Richmond Agitation Sedation Scale/Cornell Assessment of Pediatric Delirium/ scoring documentation (Fig. 1) and patients referred to psychiatry. Outcome measures included the percentage of patients screened for delirium before discharge. We conducted Plan-Do-Study Act cycles to optimize the screening process in the electronic medical record (EMR). This included creating an order set, documentation flowsheets, and prompts in the EMR for patients.
After initial implementation, we achieved an average weekly screening compliance of 76% (Fig. 1). Inclusion criteria expansion resulted in a downward compliance shift to 59%. Subsequently, the addition of the EMR checklist resulted in a center-line shift to a sustained average weekly screening compliance of 77%. An average of 82% of all eligible NICU patients received delirium screening before discharge (Fig. 2).
Using quality improvement methodology, there was increased screening and recognition of delirium in our NICU. Future research efforts could focus on assessing preventive measures and the impact of neonatal delirium on patient outcomes.
新生儿重症监护病房中谵妄并不常见,但在重症监护病房环境中会对患者预后产生不利影响。在新生儿重症监护病房中识别谵妄是解决其对新生儿预后潜在影响的必要第一步。
我们开展了一项质量改进计划,实施新生儿谵妄筛查。我们的目标是到2022年3月将新生儿重症监护病房患者的筛查率从0%提高到85%。与关键利益相关者召开了跨学科会议,以制定临床算法。我们使用标准化工具进行谵妄筛查。我们的过程指标包括护士每周对里士满躁动镇静量表/康奈尔儿科谵妄评估/评分记录的依从性(图1)以及转诊至精神科的患者。结果指标包括出院前接受谵妄筛查的患者百分比。我们进行了计划-实施-研究-改进循环,以优化电子病历(EMR)中的筛查流程。这包括创建一个医嘱集、记录流程图,并在电子病历中为患者设置提示。
初步实施后,我们实现了平均每周76%的筛查依从性(图1)。纳入标准的扩大导致依从性下降至59%。随后,添加电子病历检查表使中心线发生偏移,平均每周筛查依从性持续保持在77%。平均82%的所有符合条件的新生儿重症监护病房患者在出院前接受了谵妄筛查(图2)。
采用质量改进方法,我们新生儿重症监护病房对谵妄的筛查和识别有所增加。未来的研究工作可以侧重于评估预防措施以及新生儿谵妄对患者预后的影响。